Fast-food chain McDonald’s, an economic indicator because of its mammoth global presence, posted its worst earnings report since 2020.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
McDonald’s warned that customers might be getting sick of price hikes. It was right. Sales fell year-over-year for the first time since 2020.
A recent study adds more ammunition to the idea that disturbing the sea floor via deep sea mining could do serious ecological damage.
Pioneering online education company 2U filed for bankruptcy, even as the public writ large has gradually embraced online learning.
Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
A patent for generative neural network-based ultrasounds from medical device firm Philips could provide more data to develop AI innovations throughout…
Pfizer, Moderna, and GlaxoSmithKline are developing vaccines for RSV to fill the gap on their balance sheets.
General Motors shares tumbled after the company said its driverless taxi division, Cruise, will suspend production of the Origin robotaxi.
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.
Ryanair said it had seen its profits take a 46% nosedive, and would have to offer “materially lower” airfares for the busy summer period.
After years of spending big with little to show for it, Apple is attempting to rein in costs at Apple TV+.
Patents like this serve as a reminder that autonomous vehicles look like more than just cars themselves.
To prepare for a slowdown of global trade, US retailers spent months building a massive inventory to prevent empty shelves.
Hertz’s recent track record leaves much to be desired: the rental-car company lost nearly $2.9 billion last year.
Investor worries about a fresh batch of US tariffs have dragged LVMH shares in Paris down 23.6% so far this year.
The company plans to seek regulatory approval for the revolutionary weight loss treatment by the end of the year.